BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,213,299 | +50.6% | 235,620 | -1.8% | 2.23% | +52.6% |
| Q2 2023 | $4,126,194 | +5.0% | 239,895 | +1.2% | 1.46% | -3.0% |
| Q1 2023 | $3,929,046 | +154.0% | 236,975 | +16.7% | 1.51% | +135.6% |
| Q4 2022 | $1,546,860 | -23.9% | 203,000 | -0.8% | 0.64% | -25.3% |
| Q3 2022 | $2,033,000 | +21.7% | 204,550 | +11.2% | 0.86% | +19.0% |
| Q2 2022 | $1,670,000 | -4.5% | 183,900 | +6.7% | 0.72% | +17.3% |
| Q1 2022 | $1,749,000 | -35.8% | 172,325 | +5.5% | 0.61% | -31.2% |
| Q4 2021 | $2,726,000 | -63.2% | 163,400 | +3.5% | 0.89% | -64.9% |
| Q3 2021 | $7,401,000 | -21.0% | 157,898 | +2.8% | 2.54% | -17.9% |
| Q2 2021 | $9,368,000 | +0.7% | 153,672 | +1.7% | 3.10% | -9.5% |
| Q1 2021 | $9,307,000 | -13.2% | 151,085 | +0.2% | 3.42% | -19.0% |
| Q4 2020 | $10,726,000 | +98.7% | 150,835 | +4.9% | 4.23% | +65.8% |
| Q3 2020 | $5,397,000 | +14.1% | 143,835 | -0.9% | 2.55% | +9.0% |
| Q2 2020 | $4,732,000 | +58.0% | 145,100 | +40.5% | 2.34% | +22.3% |
| Q1 2020 | $2,994,000 | -18.2% | 103,250 | -1.1% | 1.91% | +9.3% |
| Q4 2019 | $3,659,000 | +79.0% | 104,400 | +9.7% | 1.75% | +72.8% |
| Q3 2019 | $2,044,000 | – | 95,200 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |